Search clinical trials for: Alpha-1 MP

Total 19558 results

M.M.A Tech Ltd.

Unknown

AL-2 MP-1 (Polyimide) Acetabular Liner

Osteoarthritis | Rheumatoid Arthritis | Avascular Necrosis | Ankylosing Spondylitis | Post-traumatic; Arthrosis | Congenital Dysplasia of the Hip | Injury of Hip

Israel
Grifols Therapeutics LLC

Completed

Safety and Pharmacokinetics of Alpha-1 Proteinase Inhibitor in Subjects With Alpha1-Antitrypsin Deficiency (SPARK)

Emphysema | Alpha 1-antitrypsin Deficiency (AATD)

United States
Grifols Therapeutics LLC

Terminated

Study of Human Plasma-Derived Alpha1-Proteinase Inhibitor in Subjects With New-Onset Type 1 Diabetes Mellitus

Type 1 Diabetes Mellitus

United States
Grifols Therapeutics LLC

Enrolling by invitation

Long Term Safety of Alpha1-Proteinase Inhibitor in Subjects With Alpha1 Antitrypsin Deficiency (SPARTA-OLE)

Pulmonary Emphysema in Alpha-1 Antitrypsin Deficiency

United States, New Zealand, Denmark, Australia, Finland, Estonia, Canada, Poland, Russian Federation, Sweden, France
Grifols Therapeutics LLC
Grifols Japan K.K.

Completed

Safety and Pharmacokinetics of Alpha-1 MP (Alpha1-proteinase Inhibitor (Human), Modified Process) in Participants With Alpha1-Antitrypsin Deficiency

Alpha1-Antitrypsin Deficiency

Japan
Grifols Therapeutics LLC
Grifols Japan K.K.

Completed

Long-term Safety of Alpha1-Proteinase Inhibitor (Human) in Japanese Subjects With Alpha1 Antitrypsin Deficiency (GTI1401-OLE)

Alpha1-Antitrypsin Deficiency

Japan
Grifols Therapeutics LLC

Completed

Comparison of Pharmacokinetic, Safety, Tolerability of Alpha-1 MP and Prolastin In Alpha1-antitrypsin Deficient Adults (ChAMP)

Alpha 1-Antitrypsin Deficiency

United States
Grifols Therapeutics LLC

Active, not recruiting

Efficacy and Safety of Alpha1-Proteinase Inhibitor (Human), Modified Process (Alpha-1 MP) in Subjects With Pulmonary Emphysema Due to Alpha1 Antitrypsin Deficiency (AATD) (SPARTA)

Pulmonary Emphysema in Alpha-1 PI Deficiency

United States, Australia, Denmark, New Zealand, Estonia, Poland, Russian Federation, Sweden, Brazil, Canada, France, Finland
The Ludwig Boltzmann Institute of Retinology and...

Completed

UHR-OCT and HD-OCT for Preretinal Membranes: ICG Versus Membrane Blue

Retinal Diseases

Austria
Rush Eye Associates

Completed

ILM Peeling in PDR Patients Undergoing PPV for VH

Diabetic Retinopathy | Macular Edema

Mexico
Ramos Mejía Hospital

Completed

Mechanical Power and Ventilatory Ratio in ARDS

Acute Respiratory Distress Syndrome

Argentina
Khon Kaen University

Completed

Evaluation of Consumption Safety and Effect of Mulberry Leaves and Vietnamese Coriander Based Instant Polyherbal Porridge on Working Memory and Bone Formation Markers

Healthy

Thailand
MediBeacon

Completed

Pharmacokinetics of MP-3180 and Use of Noninvasive Fluorescence Detection Device in Healthy Volunteers (ORFM-1B)

Acute Kidney Injury | Glomerular Filtration Rate

United States
Mitsubishi Tanabe Pharma Corporation

Completed

Clinical Pharmacology Study of MP-424

Chronic Hepatitis C

Korea, Republic of
Sarepta Therapeutics, Inc.
Baim Institute for Clinical Research

Completed

Safety and Efficacy of RESTEN-MP When Used in Conjunction With a Bare Metal Stent in Coronary Arteries

Coronary Artery Disease | Coronary Restenosis

Germany
Grifols Therapeutics LLC

Completed

Safety and Tolerability Trial of Inhaled Alpha1-Proteinase Inhibitor (Human), Hydrophobic Chromatography Process (Alpha-1 HC) in Subjects With Cystic Fibrosis

Cystic Fibrosis

United States
Mitsubishi Tanabe Pharma Corporation

Completed

A Pharmacokinetic Study of MP-214 in Patients With Schizophrenia

Schizophrenia

Japan
Astex Pharmaceuticals, Inc.

Completed

Safety Study to Determine the Maximum Tolerated Dose, Pharmacokinetics and Pharmacodynamics of Oral MP470, a Multitargeted Tyrosine Kinase Inhibitor, in Patients With Solid Malignancies

Solid Tumors

United States
Mitsubishi Tanabe Pharma Corporation

Completed

Pharmacokinetic/Pharmacodynamic Study of MP-513 With Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus

Japan
Seoul National University Hospital

Unknown

Collection of Anonymized Data for Improvement of Domestic Patient Monitor System

Surgical Procedure, Unspecified

Korea, Republic of
Liverpool John Moores University
University College, London; Duke-NUS Graduate Medical School; Applied Behaviour...

Unknown

A Digital Approach to Improving Carbohydrate Periodisation Behaviours in Athlete: SMART+ Study

Diet Habit

United Kingdom
Doheny Image Reading Center

Completed

Measuring Geographic Atrophy in AMD Patients Using the Nidek MP-3 Microperimetry Device

Age-related Macular Degeneration (AMD)

United States
I.R.C.C.S. Fondazione Santa Lucia

Completed

Osteopathic Manipulative Treatment Induces Functional Connectivity Changes

Osteopathic Manipulative Treatment

Italy
Sarepta Therapeutics, Inc.

Terminated

A Phase 1b Study Evaluating RESTEN-MP in Subjects With Focal de Novo Stenosis

Coronary Artery Disease | Coronary Stent Restenosis
Amore Filippo

Completed

MP-3 Biofeedback Training and Central Vision Loss

Age-Related Macular Degeneration

Italy
Washington University School of Medicine

Completed

A Prospective Case Series Evaluating Surgimend Mp® In Patients Undergoing Complex Abdominal Hernia Repair

Hernia, Ventral

United States
MediBeacon

Completed

Pharmacokinetics of MP-3180 in Healthy Volunteers (Pilot 1A)

Acute Kidney Injury | Glomerular Filtration Rate

United States
Assiut University

Not yet recruiting

Effect of Post Covid-19 Hypoxia on Placenta of Normal Pregnant Women: A Possible Role of Hypoxia Inducible Factor-1α.

Hif-1α Covid-19
Mitsubishi Tanabe Pharma Corporation
Vertex Pharmaceuticals Incorporated

Completed

A Phase 1 Study of MP-424, Peginterferon Alfa 2b, and Ribavirin in Hepatitis C

Hepatitis C

Japan
Swiss Federal Institute of Technology
Kantonsspital Baden

Completed

Multi-parametric Breast Ultrasound Imaging as a Potential Biomarker for Breast Cancer (mp-BUS)

Breast Cancer

Switzerland
Universidad Peruana Cayetano Heredia
Grand Challenges Canada; Instituto Nacional de Salud del Niño. Lima, Peru

Completed

Randomized Cluster Trial on Innovative and Standard Strategies for Neonatal Resuscitation Training (RCPNEOPERU Project) (RCPNEOPERU)

Neonatal Asphyxia

Peru
Mitsubishi Tanabe Pharma Corporation

Completed

Efficacy and Safety of MP-513 in Combination With Metformin in Patients With Type 2 Diabetes

Type 2 Diabetes Mellitus

Poland, United Kingdom, Germany, Romania, Hungary, Denmark, Lithuania
Centocor, Inc.

Completed

A Study of Safety and Effectiveness of Ustekinumab in Patients With Moderate to Severe Active Crohn's Disease Who Have Been Previously Treated With Anti-TNF Therapy

Crohn's Disease

United States, France, United Kingdom, Germany, Spain, Belgium, Israel, Australia, Canada, Netherlands, New Zealand, Austria
Mansoura University

Active, not recruiting

Can VI-RADS/ADC Accurately Stage Bladder Cancer??

Bladder Cancer | Diagnoses Disease | Bladder Disease | Bladder Urothelial Carcinoma | Bladder Neoplasm | MRI Contrast Media Adverse Reaction | Bladder Cancer Stage

Egypt
Benha University

Completed

Micropulse Transscleral Diode Laser Cyclophotocoagulation (MP-TSCPC) as a Treatment Modality for Glaucoma Patients

Glaucoma

Egypt
Mediti Pharma Inc.

Terminated

A Study of MP-101 in Dementia-Related Psychosis and/or Agitation and Aggression

Aggression | Dementia | Psychosis | Agitation | Alzheimer Dementia

United States, Canada
Jagiellonian University

Completed

Selective Versus Nonselective Alpha-blockade Prior to Pheochromocytoma Resection - Systematic Review and Meta-analysis

Pheochromocytoma

Poland
Bayer

Completed

Study to Test the Usability of a New Injector to Administer Contrast Media Into Humans for Diagnostic Purposes (PERCENT)

Computed Tomography

Australia, Netherlands
Mitsubishi Tanabe Pharma Corporation

Completed

Efficacy and Safety of MP-424, Peginterferon Alfa-2a (PEG-IFN Alfa-2a), and Ribavirin(RBV) in Treatment-Naïve or Relapsed Hepatitis C

Chronic Hepatitis C (CHC)

Japan
sigma-tau i.f.r. S.p.A.

Completed

Thymosin Alpha 1, Interferon Alpha, or Both, in Combination With Dacarbazine in Patients With Malignant Melanoma

Malignant Melanoma

France, Germany, Hungary, Italy, Poland, Portugal, Spain, Switzerland
Kamada, Ltd.

Completed

Phase II Study to Evaluate the Efficacy and Safety of Glassia® in Type-1 Diabetes

New Onset Type-1 Diabetes

Israel
Astex Pharmaceuticals, Inc.

Completed

Safety of MP470 in Combination With Standard-of-Care Chemotherapy Regimens to Treat Solid Tumors (SGI-0470-02)

Malignant Disease

United States
I.R.C.C.S. Fondazione Santa Lucia

Completed

Osteopathic Manipulative Treatments and Neurogenic Bowel Dysfunction in Patients With Spinal Cord Injuries.

Spinal Cord Injuries

Italy
U.S. Army Medical Research and Development Command

Completed

Safety/Immunogenicity/Genetic Drift of MP-12 Rift Valley Fever Vaccine (MP-12)

Rift Valley Fever

United States
Wafaa Mahmoud Amin

Withdrawn

Mental Practice Versus Proprioceptive Neuromuscular Facilitation on Strength of Upper Limb

Motor Activity

Saudi Arabia
Grifols Therapeutics LLC

Recruiting

A Study to Evaluate Safety, Tolerability and Pharmacokinetics of Two Different Doses of Alpha1-Proteinase Inhibitor Subcutaneous (Human) 15% in Participants With Alpha1-Antitrypsin Deficiency

Alpha1-Antitrypsin Deficiency

United States
Rabin Medical Center

Unknown

Safety and Efficacy of Inhaled Alpha-1 Antitrypsin in Preventing Bronchiolitis Obliterable Syndrome in Lung Transplant Recipients

Lung Transplantation | Bronchiolitis Obliterable Syndrome
Kamada, Ltd.

Completed

Study of the Safety and Efficacy of Intravenous Alpha-1 Antitrypsin in Type 1 Diabetes Mellitus

Type 1 Diabetes Mellitus

Israel
Handok Inc.

Completed

Teneligliptin(MP-513) Versus Placebo in Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus

Korea, Republic of
The Cleveland Clinic

Active, not recruiting

Sequential Hypo- and Normo-thermic Perfusion to Preserve Extended Criteria Donor Livers for Transplantation

Liver Transplantation

United States

3

Subscribe